跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
KOMBOGLYZE 2,5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
KOMBOGLYZE 2,5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 7, 2024
Approval ID
9499419b0ea0e093
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
9499419b0ea0e093
Drug Cima Aemps Name
KOMBOGLYZE 2,5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
11731008IP
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2024-10-07
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2,5 mg /1000mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
ASTRAZENECA AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
SAXAGLIPTINA
2,5 mg
METFORMINA HIDROCLORURO
1000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 7, 2024
Approval ID
9499419b0ea0e093
Type
Standard
Back to CIMA-AEMPS Approvals
KOMBOGLYZE 2,5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
